Global Choroidal Neovascularization Market Research Report 2021

Global Choroidal Neovascularization Market Research Report 2021

Table of Contents
1 Choroidal Neovascularization Market Overview
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Choroidal Neovascularization Segment by Type
1.2.1 Global Choroidal Neovascularization Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Choroidal Neovascularization Segment by Application
1.3.1 Choroidal Neovascularization Sales Comparison by Application: (2021-2027)
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Global Choroidal Neovascularization Market Size Estimates and Forecasts
1.4.1 Global Choroidal Neovascularization Revenue 2016-2027
1.4.2 Global Choroidal Neovascularization Sales 2016-2027
1.4.3 Choroidal Neovascularization Market Size by Region: 2016 Versus 2021 Versus 2027
2 Choroidal Neovascularization Market Competition by Manufacturers
2.1 Global Choroidal Neovascularization Sales Market Share by Manufacturers (2016-2021)
2.2 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Choroidal Neovascularization Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Choroidal Neovascularization Manufacturing Sites, Area Served, Product Type
2.5 Choroidal Neovascularization Market Competitive Situation and Trends
2.5.1 Choroidal Neovascularization Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Choroidal Neovascularization Players Market Share by Revenue
2.5.3 Global Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Choroidal Neovascularization Retrospective Market Scenario by Region
3.1 Global Choroidal Neovascularization Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Choroidal Neovascularization Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Choroidal Neovascularization Market Facts & Figures by Country
3.3.1 North America Choroidal Neovascularization Sales by Country
3.3.2 North America Choroidal Neovascularization Revenue by Country
3.3.3 United States
3.3.4 Canada
3.3.3 Mexico
3.4 Europe Choroidal Neovascularization Market Facts & Figures by Country
3.4.1 Europe Choroidal Neovascularization Sales by Country
3.4.2 Europe Choroidal Neovascularization Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Choroidal Neovascularization Market Facts & Figures by Region
3.5.1 Asia Pacific Choroidal Neovascularization Sales by Region
3.5.2 Asia Pacific Choroidal Neovascularization Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Indonesia
3.5.9 Thailand
3.5.10 Malaysia
3.5.11 Philippines
3.5.12 Vietnam
3.6 Latin America Choroidal Neovascularization Market Facts & Figures by Country
3.6.1 Latin America Choroidal Neovascularization Sales by Country
3.6.2 Latin America Choroidal Neovascularization Revenue by Country
3.6.3 Brazil
3.7 Middle East and Africa Choroidal Neovascularization Market Facts & Figures by Country
3.7.1 Middle East and Africa Choroidal Neovascularization Sales by Country
3.7.2 Middle East and Africa Choroidal Neovascularization Revenue by Country
3.7.3 Turkey
3.7.4 GCC Countries
3.7.5 Egypt
3.7.6 South Africa
4 Global Choroidal Neovascularization Historic Market Analysis by Type
4.1 Global Choroidal Neovascularization Sales Market Share by Type (2016-2021)
4.2 Global Choroidal Neovascularization Revenue Market Share by Type (2016-2021)
4.3 Global Choroidal Neovascularization Price by Type (2016-2021)
5 Global Choroidal Neovascularization Historic Market Analysis by Application
5.1 Global Choroidal Neovascularization Sales Market Share by Application (2016-2021)
5.2 Global Choroidal Neovascularization Revenue Market Share by Application (2016-2021)
5.3 Global Choroidal Neovascularization Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc. Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.2.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis AG Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Regeneron Pharmaceuticals Inc.
6.4.1 Regeneron Pharmaceuticals Inc. Corporation Information
6.4.2 Regeneron Pharmaceuticals Inc. Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Regeneron Pharmaceuticals Inc. Product Portfolio
6.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
6.5 Bayer AG
6.5.1 Bayer AG Corporation Information
6.5.2 Bayer AG Description and Business Overview
6.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bayer AG Product Portfolio
6.5.5 Bayer AG Recent Developments/Updates
6.6 QLT Inc.
6.6.1 QLT Inc. Corporation Information
6.6.2 QLT Inc. Description and Business Overview
6.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.6.4 QLT Inc. Product Portfolio
6.6.5 QLT Inc. Recent Developments/Updates
6.7 Sanwa Kagaku Kenkyusho Co. Ltd.
6.6.1 Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
6.6.2 Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
6.6.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product Portfolio
6.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
6.8 Promedior Inc.
6.8.1 Promedior Inc. Corporation Information
6.8.2 Promedior Inc. Description and Business Overview
6.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Promedior Inc. Product Portfolio
6.8.5 Promedior Inc. Recent Developments/Updates
6.9 Bausch Health
6.9.1 Bausch Health Corporation Information
6.9.2 Bausch Health Description and Business Overview
6.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bausch Health Product Portfolio
6.9.5 Bausch Health Recent Developments/Updates
6.10 Gilead Sciences Inc
6.10.1 Gilead Sciences Inc Corporation Information
6.10.2 Gilead Sciences Inc Description and Business Overview
6.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Gilead Sciences Inc Product Portfolio
6.10.5 Gilead Sciences Inc Recent Developments/Updates
7 Choroidal Neovascularization Manufacturing Cost Analysis
7.1 Choroidal Neovascularization Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Choroidal Neovascularization
7.4 Choroidal Neovascularization Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Choroidal Neovascularization Distributors List
8.3 Choroidal Neovascularization Customers
9 Choroidal Neovascularization Market Dynamics
9.1 Choroidal Neovascularization Industry Trends
9.2 Choroidal Neovascularization Growth Drivers
9.3 Choroidal Neovascularization Market Challenges
9.4 Choroidal Neovascularization Market Restraints
10 Global Market Forecast
10.1 Choroidal Neovascularization Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Choroidal Neovascularization by Type (2022-2027)
10.2 Choroidal Neovascularization Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Choroidal Neovascularization by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Choroidal Neovascularization by Application (2022-2027)
10.3 Choroidal Neovascularization Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Choroidal Neovascularization by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Choroidal Neovascularization by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Choroidal Neovascularization Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Choroidal Neovascularization Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Choroidal Neovascularization Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Choroidal Neovascularization Covered in This Study
Table 5. Global Choroidal Neovascularization Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Choroidal Neovascularization Sales Share by Manufacturers (2016-2021)
Table 7. Global Choroidal Neovascularization Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Choroidal Neovascularization Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Choroidal Neovascularization Manufacturing Sites and Area Served
Table 11. Manufacturers Choroidal Neovascularization Product Type
Table 12. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Choroidal Neovascularization by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Choroidal Neovascularization as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Choroidal Neovascularization Sales by Region (2016-2021) & (K Units)
Table 16. Global Choroidal Neovascularization Sales Market Share by Region (2016-2021)
Table 17. Global Choroidal Neovascularization Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Choroidal Neovascularization Sales by Country (2016-2021) & (K Units)
Table 19. North America Choroidal Neovascularization Sales Market Share by Country (2016-2021)
Table 20. North America Choroidal Neovascularization Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Choroidal Neovascularization Revenue Market Share by Country (2016-2021)
Table 22. Europe Choroidal Neovascularization Sales by Country (2016-2021) & (K Units)
Table 23. Europe Choroidal Neovascularization Sales Market Share by Country (2016-2021)
Table 24. Europe Choroidal Neovascularization Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Choroidal Neovascularization Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Choroidal Neovascularization Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Choroidal Neovascularization Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Choroidal Neovascularization Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Choroidal Neovascularization Revenue Market Share by Region (2016-2021)
Table 30. Latin America Choroidal Neovascularization Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Choroidal Neovascularization Sales Market Share by Country (2016-2021)
Table 32. Latin America Choroidal Neovascularization Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Choroidal Neovascularization Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Choroidal Neovascularization Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Choroidal Neovascularization Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Choroidal Neovascularization Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Choroidal Neovascularization Revenue Market Share by Country (2016-2021)
Table 38. Global Choroidal Neovascularization Sales (K Units) by Type (2016-2021)
Table 39. Global Choroidal Neovascularization Sales Market Share by Type (2016-2021)
Table 40. Global Choroidal Neovascularization Revenue (Million US$) by Type (2016-2021)
Table 41. Global Choroidal Neovascularization Revenue Share by Type (2016-2021)
Table 42. Global Choroidal Neovascularization Price (USD/Unit) by Type (2016-2021)
Table 43. Global Choroidal Neovascularization Sales (K Units) by Application (2016-2021)
Table 44. Global Choroidal Neovascularization Sales Market Share by Application (2016-2021)
Table 45. Global Choroidal Neovascularization Revenue (Million US$) by Application (2016-2021)
Table 46. Global Choroidal Neovascularization Revenue Share by Application (2016-2021)
Table 47. Global Choroidal Neovascularization Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Inc. Corporation Information
Table 49. Pfizer Inc. Description and Business Overview
Table 50. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Inc. Choroidal Neovascularization Product
Table 52. Pfizer Inc. Recent Developments/Updates
Table 53. F. Hoffmann-La Roche Ltd. Corporation Information
Table 54. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 55. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product
Table 57. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 58. Novartis AG Corporation Information
Table 59. Novartis AG Description and Business Overview
Table 60. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Novartis AG Choroidal Neovascularization Product
Table 62. Novartis AG Recent Developments/Updates
Table 63. Regeneron Pharmaceuticals Inc. Corporation Information
Table 64. Regeneron Pharmaceuticals Inc. Description and Business Overview
Table 65. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product
Table 67. Regeneron Pharmaceuticals Inc. Recent Developments/Updates
Table 68. Bayer AG Corporation Information
Table 69. Bayer AG Description and Business Overview
Table 70. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Bayer AG Choroidal Neovascularization Product
Table 72. Bayer AG Recent Developments/Updates
Table 73. QLT Inc. Corporation Information
Table 74. QLT Inc. Description and Business Overview
Table 75. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. QLT Inc. Choroidal Neovascularization Product
Table 77. QLT Inc. Recent Developments/Updates
Table 78. Sanwa Kagaku Kenkyusho Co. Ltd. Corporation Information
Table 79. Sanwa Kagaku Kenkyusho Co. Ltd. Description and Business Overview
Table 80. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product
Table 82. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
Table 83. Promedior Inc. Corporation Information
Table 84. Promedior Inc. Description and Business Overview
Table 85. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Promedior Inc. Choroidal Neovascularization Product
Table 87. Promedior Inc. Recent Developments/Updates
Table 88. Bausch Health Corporation Information
Table 89. Bausch Health Description and Business Overview
Table 90. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Bausch Health Choroidal Neovascularization Product
Table 92. Bausch Health Recent Developments/Updates
Table 93. Gilead Sciences Inc Corporation Information
Table 94. Gilead Sciences Inc Description and Business Overview
Table 95. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Gilead Sciences Inc Choroidal Neovascularization Product
Table 97. Gilead Sciences Inc Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Choroidal Neovascularization Distributors List
Table 101. Choroidal Neovascularization Customers List
Table 102. Choroidal Neovascularization Market Trends
Table 103. Choroidal Neovascularization Growth Drivers
Table 104. Choroidal Neovascularization Market Restraints
Table 105. Global Choroidal Neovascularization Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Choroidal Neovascularization Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Choroidal Neovascularization Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Choroidal Neovascularization Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Choroidal Neovascularization Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Choroidal Neovascularization Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Choroidal Neovascularization Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Choroidal Neovascularization Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Choroidal Neovascularization Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Choroidal Neovascularization Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Choroidal Neovascularization Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Global Choroidal Neovascularization Market Share by Type in 2020 & 2027
Figure 3. Intravenous Product Picture
Figure 4. Intravitreal Product Picture
Figure 5. Global Choroidal Neovascularization Market Share by Application in 2020 & 2027
Figure 6. Extreme Myopia
Figure 7. Malignant Myopic Degeneration
Figure 8. Age-Related Developments
Figure 9. Global Choroidal Neovascularization Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Choroidal Neovascularization Market Size 2016-2027 (US$ Million)
Figure 11. Global Choroidal Neovascularization Sales 2016-2027 (K Units)
Figure 12. Global Choroidal Neovascularization Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Choroidal Neovascularization Sales Share by Manufacturers in 2020
Figure 14. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Choroidal Neovascularization Players: Market Share by Revenue in 2020
Figure 16. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Choroidal Neovascularization Sales Market Share by Region (2016-2021)
Figure 18. Global Choroidal Neovascularization Sales Market Share by Region in 2020
Figure 19. Global Choroidal Neovascularization Revenue Market Share by Region (2016-2021)
Figure 20. Global Choroidal Neovascularization Revenue Market Share by Region in 2020
Figure 21. United States Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Mexico Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. UK Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. GCC Countries Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Egypt Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. South Africa Choroidal Neovascularization Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Choroidal Neovascularization by Type (2016-2021)
Figure 45. Sales Market Share of Choroidal Neovascularization by Application (2016-2021)
Figure 46. Sales Market Share of Choroidal Neovascularization by Application in 2020
Figure 47. Revenue Share of Choroidal Neovascularization by Application (2016-2021)
Figure 48. Revenue Share of Choroidal Neovascularization by Application in 2020
Figure 49. Manufacturing Cost Structure of Choroidal Neovascularization
Figure 50. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 51. Choroidal Neovascularization Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs